Suchergebnisse - "Ferro, Antonella"

PubPharm (4)

1

The Promher Study : An Observational Italian Study on Adjuvant Therapy for HER2-Positive, pT1a-b pN0 Breast Cancer

enthalten in: PloS one | 2015

von Gori, S. | Inno, A. | Fiorio, E. | +33

ErratumIn: PLoS One. 2015;10(9):e0139650. - PMID 26406908

2

Circulating tumor cells and response to neoadjuvant paclitaxel and HER2-targeted therapy : a sub-study from the NeoALTTO phase III trial

enthalten in: Breast (Edinburgh, Scotland) | 2013

von Azim, H. | Rothé, F. | Aura, C. | +18

3

CDC25A protein stability represents a previously unrecognized target of HER2 signaling in human breast cancer : implication for a potential clinical relevance in trastuzumab treatment

enthalten in: Neoplasia (New York, N.Y.) | 2013

von Brunetto, E. | Ferrara, A. | Rampoldi, F. | +13

4

PI3KCA mutations and/or PTEN loss in Her2-positive breast carcinomas treated with trastuzumab are not related to resistance to anti-Her2 therapy

enthalten in: Virchows Archiv : an international journal of pathology | 2012

von Barbareschi, M. | Cuorvo, L. | Girlando, S. | +10

1
[1]